Seguin Philippe, Tanguy Michèle, Laviolle Bruno, Tirel Olivier, Mallédant Yannick
Surgical Intensive Care Unit, INSERM U620, Hôpital Pontchaillou, 2 rue Henri Le Guilloux, 35033 Rennes cedex, France.
Crit Care Med. 2006 May;34(5):1514-9. doi: 10.1097/01.CCM.0000214516.73076.82.
To evaluate the effect of a regular oropharyngeal application of povidone-iodine on the prevalence of ventilator-associated pneumonia in patients with severe head trauma.
Prospective randomized study.
A surgical intensive care unit of a university hospital.
Patients with severe head trauma (Glasgow Coma Score of < or =8) expected to need ventilation for > or =2 days were prospectively randomized into three groups: those receiving nasopharynx and oropharynx rinsing with 20 mL of a 10% povidone-iodine aqueous solution, reconstituted in a 60-mL solution with sterile water (povidone-iodine group); those receiving nasopharynx and oropharynx rinsing with 60 mL of saline solution (saline group); or those undergoing a standard regimen without any instillation but with aspiration of oropharyngeal secretions (control group).
The prevalence of ventilator-associated pneumonia was compared among the three groups. A total of 98 patients were analyzed (povidone-iodine group, n = 36; saline group, n = 31; and control group, n = 31). A total of 28 cases of ventilator-associated pneumonia were diagnosed. There was a significant decrease in the rate of ventilator-associated pneumonia in the povidone-iodine group when compared with the saline and control groups (3 of 36 patients [8%] vs. 12 of 31 patients [39%] and 13 of 31 patients [42%], respectively; p = .003 and .001, respectively). The length of stay and mortality in the surgical intensive care unit were not statistically different between the three groups.
The regular administration of povidone-iodine may be an effective strategy for decreasing the prevalence of ventilator-associated pneumonia in patients with severe head trauma.
评估定期口咽应用聚维酮碘对重型颅脑外伤患者呼吸机相关性肺炎患病率的影响。
前瞻性随机研究。
一所大学医院的外科重症监护病房。
预计需要机械通气≥2天的重型颅脑外伤患者(格拉斯哥昏迷评分≤8分)被前瞻性随机分为三组:一组接受用20 mL 10%聚维酮碘水溶液经无菌水配制成60 mL溶液进行鼻咽和口咽冲洗(聚维酮碘组);一组接受用60 mL生理盐水进行鼻咽和口咽冲洗(生理盐水组);另一组采用标准方案,不进行任何滴注但抽吸口咽分泌物(对照组)。
比较三组患者呼吸机相关性肺炎的患病率。共分析了98例患者(聚维酮碘组36例,生理盐水组31例,对照组31例)。共诊断出28例呼吸机相关性肺炎。与生理盐水组和对照组相比,聚维酮碘组呼吸机相关性肺炎的发生率显著降低(分别为36例患者中的3例[8%] vs. 31例患者中的12例[39%]和31例患者中的13例[42%];p值分别为0.003和0.001)。三组患者在外科重症监护病房的住院时间和死亡率无统计学差异。
定期给予聚维酮碘可能是降低重型颅脑外伤患者呼吸机相关性肺炎患病率的有效策略。